{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:27:02Z","timestamp":1793158022702,"version":"4.5.0"},"reference-count":31,"publisher":"Society of Nuclear Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.2967\/jnumed.123.266309","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T17:00:14Z","timestamp":1711040414000},"page":"761-767","source":"Crossref","is-referenced-by-count":54,"title":["Preclinical Characterization of DPI-4452: A<sup>68<\/sup>Ga\/<sup>177<\/sup>Lu Theranostic Ligand for Carbonic Anhydrase IX"],"prefix":"10.2967","volume":"65","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Massi\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Hoehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Osterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Paschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Zboralski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bredenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Brichory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Attinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"2024050106051099000_65.5.761.1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene."},{"key":"2024050106051099000_65.5.761.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64038-2"},{"key":"2024050106051099000_65.5.761.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0642-z"},{"key":"2024050106051099000_65.5.761.4","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/7.7.611"},{"key":"2024050106051099000_65.5.761.5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-213X-9-22"},{"key":"2024050106051099000_65.5.761.6","doi-asserted-by":"publisher","DOI":"10.1177\/002215540004801203"},{"key":"2024050106051099000_65.5.761.7","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.7150\/thno.21848","article-title":"Past, present, and future: development of theranostic agents targeting carbonic anhydrase IX","volume":"7","author":"Lau","year":"2017","journal-title":"Theranostics."},{"key":"2024050106051099000_65.5.761.8","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"2024050106051099000_65.5.761.9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4261"},{"key":"2024050106051099000_65.5.761.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65569-1"},{"key":"2024050106051099000_65.5.761.11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s12253-017-0284-5","article-title":"Overexpression of FZD1 and CAIX are associated with invasion, metastasis, and poor prognosis of the pancreatic ductal adenocarcinoma","volume":"24","author":"Yang","year":"2018","journal-title":"Pathol Oncol Res."},{"key":"2024050106051099000_65.5.761.12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11307-015-0885-x","article-title":"Evaluation of CAIX and CAXII expression in breast cancer at varied O2 levels: CAIX is the superior surrogate imaging biomarker of tumor hypoxia","volume":"18","author":"Tafreshi","year":"2016","journal-title":"Mol Imaging Biol."},{"key":"2024050106051099000_65.5.761.13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/cancers14061392","article-title":"Carbonic anhydrase IX: a renewed target for cancer immunotherapy","volume":"14","author":"Campos","year":"2022","journal-title":"Cancers (Basel)."},{"key":"2024050106051099000_65.5.761.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605690"},{"key":"2024050106051099000_65.5.761.15","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.3000411"},{"key":"2024050106051099000_65.5.761.16","first-page":"5531","article-title":"Establishment and characterization of human renal cancer and normal kidney cell lines","volume":"50","author":"Ebert","year":"1990","journal-title":"Cancer Res."},{"key":"2024050106051099000_65.5.761.17","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1038\/s41598-019-51445-w","article-title":"Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts","volume":"9","author":"Garousi","year":"2019","journal-title":"Sci Rep."},{"key":"2024050106051099000_65.5.761.18","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.3748\/wjg.v11.i17.2616","article-title":"Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa","volume":"11","author":"Kivela","year":"2005","journal-title":"World J Gastroenterol."},{"key":"2024050106051099000_65.5.761.19","first-page":"248","article-title":"Radiation dosimetry of 131I-19-iodocholesterol: the pitfalls of using tissue concentration data [reply]","volume":"16","author":"Kirschner","year":"1975","journal-title":"J Nucl Med."},{"key":"2024050106051099000_65.5.761.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.114165"},{"key":"2024050106051099000_65.5.761.21","first-page":"35\u201348","article-title":"Tolerance of normal tissue to therapeutic radiation","volume":"1","author":"Emami","year":"2013","journal-title":"Reports of Radiotherapy and Oncology."},{"key":"2024050106051099000_65.5.761.22","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000691"},{"key":"2024050106051099000_65.5.761.23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamaoncol.2016.4419","article-title":"Adjuvant weekly girentuximab following nephrectomy for high-risk renal cell carcinoma: the ARISER randomized clinical trial","volume":"3","author":"Chamie","year":"2017","journal-title":"JAMA Oncol."},{"key":"2024050106051099000_65.5.761.24","first-page":"327","article-title":"Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re","volume":"45","author":"Brouwers","year":"2004","journal-title":"J Nucl Med."},{"key":"2024050106051099000_65.5.761.25","doi-asserted-by":"publisher","DOI":"10.2310\/7290.2014.00031"},{"key":"2024050106051099000_65.5.761.26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.eururo.2015.11.033","article-title":"Phase 2 study of lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma","volume":"69","author":"Muselaers","year":"2016","journal-title":"Eur Urol."},{"key":"2024050106051099000_65.5.761.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.08.024"},{"key":"2024050106051099000_65.5.761.28","doi-asserted-by":"publisher","DOI":"10.1007\/BF03027399"},{"key":"2024050106051099000_65.5.761.29","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2014.1741"},{"key":"2024050106051099000_65.5.761.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.075101"},{"key":"2024050106051099000_65.5.761.31","unstructured":"Borrego I Massiere F Attinger A . Safety assessment of DPI-4452, a cyclic peptide targeting carbonic anhydrase IX. Poster presented at: 43rd Annual Meeting of the American College of Toxicology; Denver, CO; November 13\u201316, 2022; P525."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.266309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T15:01:01Z","timestamp":1714575661000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.266309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.2967\/jnumed.123.266309"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.266309","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]}}}